Herbertson R A, Scarsbrook A F, Lee S T, Tebbutt N, Scott A M
Ludwig Institute for Cancer Research, Melbourne Centre for Clinical Sciences, Austin Health, Heidelberg, Victoria, Australia.
Clin Radiol. 2009 Mar;64(3):225-37. doi: 10.1016/j.crad.2008.08.008. Epub 2008 Oct 23.
Positron-emission tomography-computed tomography (PET/CT) is rapidly being integrated into the imaging pathways of several different tumour types, most frequently using the glucose analogue 2- [(18)F]-fluoro-2-deoxy-D-glucose (FDG). Integrated FDG-PET/CT combines functional and anatomical imaging to improve sensitivity and specificity of tumour detection. The aim of this article is to review the established, emerging, and future roles of FDG-PET/CT in the management of patients with colorectal cancer (CRC).
正电子发射断层扫描-计算机断层扫描（PET/CT）正迅速融入多种不同肿瘤类型的成像流程中，最常使用的是葡萄糖类似物2-[(18)F]-氟-2-脱氧-D-葡萄糖（FDG）。一体化FDG-PET/CT结合了功能成像和解剖成像，以提高肿瘤检测的灵敏度和特异性。本文旨在综述FDG-PET/CT在结直肠癌（CRC）患者管理中的既定、新兴及未来作用。
